TAI · 6446.TW
PharmaEssentia Corporation
NT$1,190.00-NT$50.00 (-4.03%)
PharmaEssentia Corporation’s quoted price sits in the upper half of its reported 52-week range, 27.66% below the high.
Loading market information…
TWO · 4167.TWO · TWD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Savior Lifetec Corp.’s quoted price sits in the upper half of its reported 52-week range, 16.08% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Savior Lifetec Corp.’s forward annual dividend is NT$0.80 per share, paid annual. The forward yield is 4.0% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Savior Lifetec Corp.’s next earnings report is currently expected on Nov 5, 2026, with estimated earnings per share of NT$0.27. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Savior Lifetec Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various carbapenem generic drugs and injections, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, meropenem, and ertapenem products. The company was founded in 1993 and is headquartered in Tainan City, Taiwan.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:15 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 | May 2, 2025 | NT$1.22+351.85% vs estimate | NT$263.86M-49.74% vs estimate |
|---|
| Q4 2024 | Mar 6, 2025 | NT$0.15-28.57% vs estimate | NT$276.94M-50.72% vs estimate |
|---|
| Q3 2024 | Nov 7, 2024 | NT$0.13+18.18% vs estimate | NT$332.46M-25.29% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$1,190.00-NT$50.00 (-4.03%)
PharmaEssentia Corporation’s quoted price sits in the upper half of its reported 52-week range, 27.66% below the high.
NT$159.00-NT$2.50 (-1.55%)
Lin BioScience, Inc.’s quoted price sits in the upper half of its reported 52-week range, 23.19% below the high.
NT$379.00-NT$13.00 (-3.32%)
Bora Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 41.78% below the high.
NT$79.90-NT$0.50 (-0.62%)
TTY Biopharm Company Limited’s quoted price sits in the upper half of its reported 52-week range, 8.16% below the high.
NT$76.80+NT$0.30 (+0.39%)
SYN-TECH Chem. & Pharm. Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 17.42% below the high.
NT$25.95-NT$0.95 (-3.53%)
Easywell Biomedicals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 42.2% below the high.
NT$30.10-NT$0.40 (-1.31%)
Nang Kuang Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.04% below the high.
NT$40.05-NT$1.50 (-3.61%)
Winston Medical Supply Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 63.92% below the high.
